Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Jarvis+ JAR Jan 27, 2021 0.00 -10.09   
 Jibrel Network Token JNT Jan 27, 2021 0.04 -2.28   
 JOYS JOYS Jan 27, 2021 0.01 +15.70   
 Jupiter JUP Jan 27, 2021 0.00 -0.66   
 JUST JST Jan 27, 2021 0.03 -2.26   
 Kadena KDA Jan 27, 2021 0.16 -4.46   
 Kahsh KSH Jan 27, 2021 0.02 -0.64   
 Kalkulus KLKS Jan 27, 2021 0.00 +32.49   
 Karatgold coin KBC Jan 27, 2021 0.00 -16.39   
 KardiaChain KAI Jan 27, 2021 0.02 +1.28   
 KATZcoin KAT Jan 27, 2021 0.00 -0.35   
 Kava KAVA Jan 27, 2021 2.21 -3.62   
 Kcash KCASH Jan 27, 2021 0.02 -2.59   
 KeyCoin KEY Jan 27, 2021 0.00 +8.78   
 King DAG KDAG Jan 27, 2021 0.26 +7.32   
 Klaytn KLAY Jan 27, 2021 0.55 +0.49   
 Komodo KMD Jan 27, 2021 0.58 -2.47   
 KRATOS TOS Jan 27, 2021 0.00 -0.66   
 Kryll KRL Jan 27, 2021 0.23 -1.21   
 Kucoin KCS Jan 27, 2021 1.15 +0.54   
 Kusama KSM Jan 27, 2021 96.56 -1.21   
 Kyber Network KNC Jan 27, 2021 1.25 -4.00   
 Lambda LAMB Jan 27, 2021 0.02 -1.74   
 Lamden Tau TAU Jan 27, 2021 0.02 +7.23   
 LatiumX LATX Jan 27, 2021 0.00 +0.10   
 LAToken LA Jan 27, 2021 0.03 +2.92   
 LBRY Credits LBC Jan 27, 2021 0.11 -1.44   
 LCX LCX Jan 27, 2021 0.02 -13.09   
 Legolas Exchange LGO Jan 27, 2021 0.04 -2.29   
 LemoChain LEMO Jan 27, 2021 0.00 -1.63   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Data:


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
Free Trial Now